AM

Ashwini Manoj Navtake

Active Director Director DIN 10479842
DIN 10479842 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashwini Manoj Navtake

Data last updated:

Ashwini Manoj Navtake is a Director at Pediabery Lifesciences Private Limited (since 2024) and Director at Ecopolis Lifesciences Private Limited (since 2024). The companies operate in Pharma.

DIN 10479842
Primary Designation Director
Industry Pharma
First Appointment 25 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20242024Active
Director25 Jan 20242024Active

Board colleagues of Ashwini Manoj Navtake

Directorship timeline

Open interactive timeline →
Pediabery Lifesciences Private Limited
Ecopolis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ashwini Manoj Navtake

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwini Manoj Navtake

Ashwini Manoj Navtake currently holds 2 directorships: Pediabery Lifesciences Private Limited (Director, since 10 Apr 2024); Ecopolis Lifesciences Private Limited (Director, since 25 Jan 2024).

Ashwini Manoj Navtake was first appointed on 25 Jan 2024 as Director at Ecopolis Lifesciences Private Limited.

The current boards of Ashwini Manoj Navtake's companies include Pranita Havgirao Yedde (Pediabery Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available